ATE239008T1 - Verfahren zur herstellung von (+/-) calanolide a und zwischenprodukte dafür - Google Patents
Verfahren zur herstellung von (+/-) calanolide a und zwischenprodukte dafürInfo
- Publication number
- ATE239008T1 ATE239008T1 AT95929365T AT95929365T ATE239008T1 AT E239008 T1 ATE239008 T1 AT E239008T1 AT 95929365 T AT95929365 T AT 95929365T AT 95929365 T AT95929365 T AT 95929365T AT E239008 T1 ATE239008 T1 AT E239008T1
- Authority
- AT
- Austria
- Prior art keywords
- calanolide
- producing
- intermediate products
- products therefor
- therefor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Fats And Perfumes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/285,655 US5489697A (en) | 1994-08-03 | 1994-08-03 | Method for the preparation of (+)-calanolide A and intermediates thereof |
| PCT/US1995/009804 WO1996004263A1 (en) | 1994-08-03 | 1995-08-02 | Method for the preparation of (±)-calanolide a and intermediates thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE239008T1 true ATE239008T1 (de) | 2003-05-15 |
Family
ID=23095160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95929365T ATE239008T1 (de) | 1994-08-03 | 1995-08-02 | Verfahren zur herstellung von (+/-) calanolide a und zwischenprodukte dafür |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5489697A (de) |
| EP (3) | EP1308448A1 (de) |
| JP (1) | JP3043813B2 (de) |
| AT (1) | ATE239008T1 (de) |
| AU (1) | AU704247B2 (de) |
| CA (1) | CA2196656C (de) |
| DE (1) | DE69530592T2 (de) |
| MY (1) | MY118279A (de) |
| WO (1) | WO1996004263A1 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6774141B1 (en) * | 1992-03-31 | 2004-08-10 | The United States Of America As Represented By The Secretary Of Health And Human Services | Calanolide and related antiviral compounds, compositions, and uses thereof |
| WO1994014789A1 (en) * | 1992-12-23 | 1994-07-07 | Smithkline Beecham Corporation | Coumarin derivatives as retroviral inhibitors |
| US6277879B1 (en) | 1994-08-03 | 2001-08-21 | Sarawak Medichem Pharmaceuticals, Inc. | Calanolide analogues and methods of their use |
| EP1071658B1 (de) * | 1998-04-17 | 2004-06-16 | Parker Hughes Institute | Btk inhibitoren und verfahren zur identifizierung und verwendung |
| US6303652B1 (en) | 1998-08-21 | 2001-10-16 | Hughes Institute | BTK inhibitors and methods for their identification and use |
| US6306897B1 (en) | 1999-03-19 | 2001-10-23 | Parker Hughes Institute | Calanolides for inhibiting BTK |
| WO2000064903A2 (en) | 1999-04-26 | 2000-11-02 | Sarawak Medichem Pharmaceuticals, Inc. | Methods for preparing antiviral calanolide compounds |
| JP2002193971A (ja) * | 2000-12-22 | 2002-07-10 | Kuraray Co Ltd | カラノリドａおよびその中間体の製造方法 |
| US6670383B2 (en) | 2001-03-16 | 2003-12-30 | Advanced Life Sciences, Inc. | Pyranocoumarin compounds as a novel pharmacophore with anti-TB activity |
| US20030176494A1 (en) * | 2001-11-16 | 2003-09-18 | Ze-Qi Xu | Novel coumarin and chromene compounds and methods of preparation and use thereof for treating or preventing viral infections |
| WO2003076444A1 (en) * | 2002-03-08 | 2003-09-18 | Kuraray Co., Ltd. | Intermediates for production of (+)-calanolide a, processes for production of the intermediates and process for producing (+)-calanolide a with the same |
| US6777562B1 (en) * | 2003-02-19 | 2004-08-17 | Dow Global Technologies Inc. | Preparation of a trans-calanolide ketone intermediate and chiral separation of calanolide alcohols to give racemic calanolide A |
| WO2004085406A1 (en) | 2003-03-24 | 2004-10-07 | F. Hoffmann-La Roche Ag | Benzyl-pyridazinons as reverse transcriptase inhibitors |
| JP2005314260A (ja) * | 2004-04-28 | 2005-11-10 | Japan Science & Technology Agency | フラボンｃ配糖体の製法 |
| WO2006011047A1 (en) * | 2004-07-23 | 2006-02-02 | Pharmacia & Upjohn Company Llc | Enantioselective method for separing substituted 2-trifluoromethyl-2h-chromene-3-carboxylic acid derivatives |
| CN101291905A (zh) | 2005-10-19 | 2008-10-22 | 弗·哈夫曼-拉罗切有限公司 | 苯乙酰胺nnrt抑制剂 |
| AU2007286345B2 (en) | 2006-08-16 | 2012-03-08 | F. Hoffmann-La Roche Ag | Non-nucleoside reverse transcriptase inhibitors |
| JP5415957B2 (ja) | 2006-12-13 | 2014-02-12 | エフ．ホフマン−ラ ロシュ アーゲー | 非ヌクレオシド逆転写酵素阻害剤としての２−（ピペリジン−４−イル）−４−フェノキシ−又はフェニルアミノ−ピリミジン誘導体 |
| MX2009012704A (es) | 2007-05-30 | 2009-12-08 | Hoffmann La Roche | Inhibidores de transcriptasa inversa de no nucleosidos. |
| KR20100085155A (ko) * | 2007-11-05 | 2010-07-28 | 인스티투트 오브 마타리아 메디카, 차이니즈 아카데미 오브 메디칼 사이언스 | 테트라환형디피라닐 쿠마린 및 이들의 항-ｈｉｖ와 항-결핵 용도 |
| KR101610607B1 (ko) | 2007-12-21 | 2016-04-07 | 에프. 호프만-라 로슈 아게 | 헤테로사이클릭 항바이러스 화합물 |
| WO2011077100A1 (en) | 2009-12-24 | 2011-06-30 | Cipla Limited | Antiretroviral composition |
| RU2458944C1 (ru) * | 2011-03-15 | 2012-08-20 | Государственное образовательное учреждение высшего профессионального образования Кемеровский технологический институт пищевой промышленности | Способ получения коллодиевой пленки центробежным методом |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994014789A1 (en) * | 1992-12-23 | 1994-07-07 | Smithkline Beecham Corporation | Coumarin derivatives as retroviral inhibitors |
-
1994
- 1994-08-03 US US08/285,655 patent/US5489697A/en not_active Expired - Lifetime
-
1995
- 1995-08-02 CA CA2196656A patent/CA2196656C/en not_active Expired - Fee Related
- 1995-08-02 JP JP8506741A patent/JP3043813B2/ja not_active Expired - Fee Related
- 1995-08-02 EP EP03000557A patent/EP1308448A1/de not_active Withdrawn
- 1995-08-02 AT AT95929365T patent/ATE239008T1/de not_active IP Right Cessation
- 1995-08-02 DE DE69530592T patent/DE69530592T2/de not_active Expired - Lifetime
- 1995-08-02 WO PCT/US1995/009804 patent/WO1996004263A1/en active IP Right Grant
- 1995-08-02 AU AU32746/95A patent/AU704247B2/en not_active Expired
- 1995-08-02 EP EP00112868A patent/EP1054007A3/de not_active Withdrawn
- 1995-08-02 EP EP95929365A patent/EP0775130B1/de not_active Expired - Lifetime
-
1997
- 1997-01-31 MY MYPI97000394A patent/MY118279A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP3043813B2 (ja) | 2000-05-22 |
| EP0775130A1 (de) | 1997-05-28 |
| DE69530592D1 (de) | 2003-06-05 |
| AU704247B2 (en) | 1999-04-15 |
| JPH09512829A (ja) | 1997-12-22 |
| EP1308448A1 (de) | 2003-05-07 |
| DE69530592T2 (de) | 2004-03-18 |
| US5489697A (en) | 1996-02-06 |
| MX9700782A (es) | 1997-09-30 |
| EP0775130B1 (de) | 2003-05-02 |
| EP1054007A2 (de) | 2000-11-22 |
| WO1996004263A1 (en) | 1996-02-15 |
| MY118279A (en) | 2004-09-30 |
| CA2196656C (en) | 2010-03-23 |
| AU3274695A (en) | 1996-03-04 |
| EP1054007A3 (de) | 2000-11-29 |
| CA2196656A1 (en) | 1996-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69530592D1 (de) | Verfahren zur herstellung von (+/-) calanolide a und zwischenprodukte dafür | |
| ATE283264T1 (de) | Zwischenprodukte zur herstellung von metallproteinasehemmern | |
| DE69322094D1 (de) | Heterogene membrane und verfahren zur herstellung | |
| DE69514950D1 (de) | Herstellung von imitierten Kunstwerken | |
| DE69500808D1 (de) | Verfahren zur herstellung von profilierten durchgangsöffnungen | |
| DE69624976D1 (de) | Verfahren zur Herstellung von MOS-Leistungstransistoren | |
| FI960949A0 (fi) | Uusi lipaasi, lipaasia tuottavat mikro-organismit, menetelmä lipaasin tuottamiseksi ja lipaasin käyttö | |
| AT384007B (de) | Verfahren zur herstellung von synthesegasen sowie vorrichtung zur durchfuehrung des verfahrens | |
| DE69713022D1 (de) | Verfahren zur Herstellung von Unterkleidung | |
| DE69503960D1 (de) | Verfahren zur Herstellung von Bisphenol | |
| DE69508793D1 (de) | Verfahren zur herstellung von perfluorkohlenstoffen | |
| DE59302743D1 (de) | Verfahren zur Herstellung von Diaminen | |
| DE69502384D1 (de) | Prozess zur herstellung von polyarylenetherketonen | |
| DE69521175D1 (de) | Verfahren zur Herstellung von Xanthangummi | |
| ATE199709T1 (de) | Verfahren zur herstellung von (+)compactin und (+)mevinolin derivaten mit beta-hydroxy-delta- lactonresten | |
| DE59504792D1 (de) | Verfahren zur Herstellung von Serienventilen | |
| DE59609854D1 (de) | Verfahren zur herstellung von verkappten polyarylenethern | |
| DE69221745D1 (de) | Verfahren zur kombinierten Herstellung von organischen Zusammenstellungen und Energie | |
| DE59300418D1 (de) | Verfahren zur Herstellung von natürlichen Antioxidantien. | |
| DE69321848D1 (de) | Verfahren zur herstellung von 1,1,1,2,3,3-hexafluorpropan und von tetrafluorchlorpropen | |
| DE69630038D1 (de) | Verfahren zur herstellung und aufreinigung von enzymen | |
| DE69310232D1 (de) | Verfahren zur Herstellung von Organomonochlorsilan | |
| DE69327203D1 (de) | Verfahren zur Herstellung von Metallocenen | |
| DE69313297D1 (de) | Benzofuranone, benzodifurantrione und verfahren zur herstellung von benzodifurandionen | |
| DE69502001D1 (de) | Herstellung von uranoxid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |